Why is Brooks Lab. falling/rising?

As of 09-Jul, Brooks Laboratories Ltd is experiencing a price increase, with the current price at Rs 142.35, reflecting a rise of Rs 2.75 or 1.97%. Today's price summary indicates that the stock has outperformed its sector by 1.77%, despite trading within a narrow range and exhibiting high volatility with an intraday volatility of 634.52%. The stock is also trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 390.81% compared to the 5-day average. Positive results from March 25, including the highest net sales for the quarter, and increased institutional investor participation, which now holds 10.43% of the company, have contributed to the stock's recent upward movement.
In the broader market context, Brooks Laboratories Ltd's performance over the past month shows a return of 9.54%, which is significantly higher than the benchmark Sensex's return of 1.32%. However, the stock's year-to-date performance remains negative at -23.03%, contrasting with the Sensex's positive return of 6.91%. While the stock has generated a remarkable return of 62.87% over the past year, concerns about its long-term fundamental strength, including a weak return on equity and poor growth in net sales, may temper investor enthusiasm. Despite these challenges, the stock's recent performance and increased institutional interest suggest a positive outlook in the short term.